Sep 27, 2021

Low-cost blood test could diagnose Alzheimer’s up to 20 years before symptoms appear

Alzheimers low cost blood test

To receive a diagnosis of Alzheimer’s disease today, doctors use cognitive tests, which only detect changes in the brain once symptoms are already present.

Professor Ralph Martins, Neurobiologist at Macquarie University Department of Biomedical Sciences Research, told HelloCare elevated levels of certain proteins in the blood are also an indicator of Alzheimer’s disease and can be picked up on brain scans.

However, the scans cost up to $3,000 each and the health system simply doesn’t have the capacity to screen whole populations.

But now a Macquarie University study has shown older adults with no cognitive deficits but whose brain scans reveal elevated levels of the proteins associated with Alzheimer’s disease also have higher levels of Alzheimer’s-related proteins in their blood compared with adults with normal brain scans. 

Due to improved technology, the Macquarie University study was able to identify minuscule levels of the proteins in the blood, a feat previously impossible because the volumes are so low.

Professor Martins said the new tool is 1,000 times more powerful than previous tools.

The study was funded by Anglicare, and 100 Anglicare retirement village residents took part.

All participants had no memory impairment. But scans revealed that one-third of the participants had high levels of amyloid in their brain, while two-thirds had “healthy” levels of the protein.

The highest level of accuracy (90%) was in the detection of green fluorescent protein (GFP), which makes it better than any other clinical method of diagnosing Alzheimer’s disease.

The study also looked at the participants after 12 months and found the levels of protein in the blood increased over time.

“So not only is it a diagnostic marker, we can also follow the progression of the disease,” Professor Martins said. “That’s what makes it even more exciting.”

Professor Martins believes the blood tests have the potential to provide a diagnosis of Alzheimer’s disease 15 to 20 years before symptoms appear.

There is currently only one drug treatment for Alzheimer’s disease, Aduhelm, which has been approved for use in the United States, but study results have been mixed. Some studies have shown the drug reduces the levels of protein in the brain, while others failed to show any benefit.

Nevertheless, the hope is that early intervention in the removal of amyloid proteins from the brain may prevent the disease from progressing.

The impact on the treatment of Alzheimer’s could be “huge”, he said.

Dr Pratishtha Chatterjee, lead author of the study and research fellow at Macquarie University Department of Biomedical Sciences Research, said, “These findings will allow more cost-effective screening and prognosis in clinical trials.”

Approximately 300,000 Australians currently have Alzheimer’s disease. There is no cure. The blood tests have the potential not only to provide early diagnosis and prevention of the onset of symptoms, they may also be used in the evaluation of drugs for treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. I live in perth. I have a strong family with 3 first degree relatives (all sisters) with AD. One has passed way with the disease. I have all of the test results showing ‘possible’ AD in other words – results unequivocle. I would like to have the blood test – is it posssible? How much will it cost??


‘Escaping the Rabbit Hole’: How bullying in the aged care workforce contributed to my depression

In her book titled ‘Escaping the Rabbit Hole’, Tracey Maxfield writes candidly about her experiences with depression. Here, she writes for HelloCare about her experiences working in the aged care sector, where she was subjected to bullying that triggered such crippling depression she has not been able to work since. After working for seven years in community nursing and then a short stint in a... Read More

What Do the Best Nursing Homes All Have in Common?

Recent media coverage of aged care homes has shone a light to some of the more horrific things that are happening to older Australians in care. But among the various homes that are being closed down, reported for abuse or simple offering poor quality of care, there are many places that are doing things right. A... Read More

Distinguished professor neglected in nursing home, royal commission hears

The Royal Commission into Aged Care Quality and Safety hearings in Hobart this week have focused on two aged care facilities operated by Southern Cross Care Tasmania, Yaraandoo and Glenara Lakes. The forensic case study has revealed dangerous medication mismanagement, neglect, poor leadership, and staff shortages. The focus has been on the governance practices of... Read More